It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely die from the ...

Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient ...

CAEL-101 – a targeted anti-fibril therapy – is chasing after Johnson & Johnson's Darzalex Faspro (daratumumab and ... patients have generally received chemotherapy in the absence of any ...

That alliance also generated Darzalex (daratumumab ... HDAC inhibitors and chemotherapy. Ultimately, the aim is to extend the time to relapse and prevent tumour resistance developing, in ...

So if patients received daratumumab [Darzalex]/pomalidomide [Pomalyst]/dexamethasone ... A lot of times patients will complain about "chemo brain," the brain fog after they receive their therapies. So ...

Ongoing clinical trials investigate combinations of daratumumab with various anti-plasma cell regimens ... Of the 124 patients for which induction chemotherapy was known, 83% received a ...

New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer a longer progression free survival for patients with newly diagnosed ...

Most people with cancer pass away from the complications of their cancer rather than cancer treatments, such as chemotherapy. It’s extremely difficult to determine whether there’s a ...

Neoadjuvant chemotherapy is a course of chemotherapy that’s given before your primary treatment, which is often surgery. Neoadjuvant chemotherapy specifically refers to chemotherapy administered ...